These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 30890477)
41. Promoter polymorphisms of the HLA-G gene, but not the HLA-E and HLA-F genes, is associated with non-segmental vitiligo patients in the Korean population. Kim SK; Hong MS; Shin MK; Uhm YK; Chung JH; Lee MH Arch Dermatol Res; 2011 Nov; 303(9):679-84. PubMed ID: 21847675 [TBL] [Abstract][Full Text] [Related]
42. The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Tazi-Ahnini R; McDonagh AJ; Wengraf DA; Lovewell TR; Vasilopoulos Y; Messenger AG; Cork MJ; Gawkrodger DJ Br J Dermatol; 2008 Sep; 159(3):591-6. PubMed ID: 18616774 [TBL] [Abstract][Full Text] [Related]
43. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women. Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818 [TBL] [Abstract][Full Text] [Related]
44. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. Jin Y; Birlea SA; Fain PR; Spritz RA J Invest Dermatol; 2007 Nov; 127(11):2558-62. PubMed ID: 17637824 [TBL] [Abstract][Full Text] [Related]
45. Analysis of inducible nitric oxide synthase gene polymorphisms in vitiligo in Han Chinese people. Zhang Y; Li C; Li K; Liu L; Jian Z; Gao T PLoS One; 2011; 6(12):e27077. PubMed ID: 22205923 [TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligo. Al-Harthi F; Zouman A; Arfin M; Tariq M; Al-Asmari A Genet Mol Res; 2013 Jul; 12(3):2196-204. PubMed ID: 23884763 [TBL] [Abstract][Full Text] [Related]
47. The association of functional polymorphisms in the aryl hydrocarbon receptor (AHR) gene with the risk of vitiligo in Han Chinese populations. Wang XW; Li K; Guo S; Qiang HN; Liu L; Song P; Wei C; Yi XL; Jian Z; Li Q; Li CY; Gao TW Br J Dermatol; 2012 May; 166(5):1081-7. PubMed ID: 22211302 [TBL] [Abstract][Full Text] [Related]
48. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations. Li M; Gao Y; Li C; Liu L; Li K; Gao L; Wang G; Zhang Z; Gao T J Dermatol Sci; 2009 Mar; 53(3):176-81. PubMed ID: 19004621 [TBL] [Abstract][Full Text] [Related]
49. Correlation of E-cadherin gene polymorphisms and epidermal growth factor receptor mutation in lung adenocarcinoma. Huang CY; Hsieh MJ; Liu TC; Chiang WL; Liu MC; Yang SF; Tsao TC Int J Med Sci; 2018; 15(8):765-770. PubMed ID: 30008585 [TBL] [Abstract][Full Text] [Related]
50. Association study between vitiligo and autoimmune-related genes CYP27B1, REL, TNFAIP3, IL2 and IL21. Martins LT; Frigeri HR; de Castro CCS; Mira MT Exp Dermatol; 2020 Jun; 29(6):535-538. PubMed ID: 32282963 [TBL] [Abstract][Full Text] [Related]
51. Association of Nod-like receptor protein-1 (rs2670660) and Toll-like receptor-4 (rs4986790) with non-segmental vitiligo: A case-control study in South Indian population. Rajendiran KS; Rajappa M; Chandrashekar L; Thappa DM Int J Immunogenet; 2019 Oct; 46(5):321-330. PubMed ID: 31293094 [TBL] [Abstract][Full Text] [Related]
52. The catalase gene promoter and 5'-untranslated region variants lead to altered gene expression and enzyme activity in vitiligo. Mansuri MS; Jadeja SD; Singh M; Laddha NC; Dwivedi M; Begum R Br J Dermatol; 2017 Dec; 177(6):1590-1600. PubMed ID: 28542879 [TBL] [Abstract][Full Text] [Related]
53. Association between exonic polymorphisms of human leukocyte antigen-G gene and non-segmental vitiligo in the Korean population. Kim SK; Kwon HE; Jeong KH; Shin MK; Lee MH Indian J Dermatol Venereol Leprol; 2022; 88(6):749-754. PubMed ID: 35389019 [TBL] [Abstract][Full Text] [Related]
54. Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population. Singh M; Mansuri MS; Jadeja SD; Marfatia YS; Begum R Indian J Dermatol Venereol Leprol; 2018; 84(3):285-291. PubMed ID: 29620037 [TBL] [Abstract][Full Text] [Related]
55. Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. Laddha NC; Dwivedi M; Begum R PLoS One; 2012 Dec; 7(12):e52298. PubMed ID: 23284977 [TBL] [Abstract][Full Text] [Related]
56. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases. Saeki M; Watanabe M; Inoue N; Tokiyoshi E; Takuse Y; Arakawa Y; Hidaka Y; Iwatani Y Autoimmunity; 2016 Dec; 49(8):514-522. PubMed ID: 27808570 [TBL] [Abstract][Full Text] [Related]
57. Association between an HLA-G 14 bp insertion/deletion polymorphism and non-segmental vitiligo in the Korean population. Jeong KH; Kim SK; Kang BK; Chung JH; Shin MK; Lee MH Arch Dermatol Res; 2014 Aug; 306(6):577-82. PubMed ID: 24639245 [TBL] [Abstract][Full Text] [Related]
58. Elevated X-Box Binding Protein1 Splicing and Interleukin-17A Expression Are Associated With Active Generalized Vitiligo in Gujarat Population. Jadeja SD; Vaishnav J; Bharti AH; Begum R Front Immunol; 2021; 12():801724. PubMed ID: 35046957 [TBL] [Abstract][Full Text] [Related]
59. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer. Chien MH; Chou LS; Chung TT; Lin CH; Chou MY; Weng MS; Yang SF; Chen MK Head Neck; 2012 Mar; 34(3):405-11. PubMed ID: 21472888 [TBL] [Abstract][Full Text] [Related]
60. Association of GZMB polymorphisms and susceptibility to non-segmental vitiligo in a Korean population. Jeong KH; Kim SK; Seo JK; Shin MK; Lee MH Sci Rep; 2021 Jan; 11(1):397. PubMed ID: 33431938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]